Report Detail
Global Acute Heart Failure (AHF) Therapeutics Market Insights, Forecast to 2025
- RnM2873274 |
- 20 February, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
The global Acute Heart Failure (AHF) Therapeutics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Acute Heart Failure (AHF) Therapeutics market based on company, product type, end user and key regions.
This report studies the global market size of Acute Heart Failure (AHF) Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Acute Heart Failure (AHF) Therapeutics in these regions.
This research report categorizes the global Acute Heart Failure (AHF) Therapeutics market by top players/brands, region, type and end user. This report also studies the global Acute Heart Failure (AHF) Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer AG
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Cytokinetics, Inc.
Merck & Co.
Novartis AG
Orion Corporation
PhaseBio Pharmaceuticals, Inc
Market size by Product
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Others
Market size by End User
Hospital
Clinic
Home Care
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Acute Heart Failure (AHF) Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Acute Heart Failure (AHF) Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Acute Heart Failure (AHF) Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Acute Heart Failure (AHF) Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Acute Heart Failure (AHF) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Acute Heart Failure (AHF) Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Acute Heart Failure (AHF) Therapeutics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Acute Heart Failure (AHF) Therapeutics Market Size Growth Rate by Product
- 1.4.2 B-Blockers
- 1.4.3 Calcium Channel Blockers
- 1.4.4 Cardiac Glycosides
- 1.4.5 Diuretics
- 1.4.6 Morphine
- 1.4.7 Vasodilators/Nitrates
- 1.4.8 Others
- 1.5 Market by End User
- 1.5.1 Global Acute Heart Failure (AHF) Therapeutics Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Home Care
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Acute Heart Failure (AHF) Therapeutics Market Size
- 2.1.1 Global Acute Heart Failure (AHF) Therapeutics Revenue 2014-2025
- 2.1.2 Global Acute Heart Failure (AHF) Therapeutics Sales 2014-2025
- 2.2 Acute Heart Failure (AHF) Therapeutics Growth Rate by Regions
- 2.2.1 Global Acute Heart Failure (AHF) Therapeutics Sales by Regions
- 2.2.2 Global Acute Heart Failure (AHF) Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Acute Heart Failure (AHF) Therapeutics Sales by Manufacturers
- 3.1.1 Acute Heart Failure (AHF) Therapeutics Sales by Manufacturers
- 3.1.2 Acute Heart Failure (AHF) Therapeutics Sales Market Share by Manufacturers
- 3.1.3 Global Acute Heart Failure (AHF) Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Acute Heart Failure (AHF) Therapeutics Revenue by Manufacturers
- 3.2.1 Acute Heart Failure (AHF) Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Acute Heart Failure (AHF) Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.3 Acute Heart Failure (AHF) Therapeutics Price by Manufacturers
- 3.4 Acute Heart Failure (AHF) Therapeutics Manufacturing Base Distribution, Product Types
- 3.4.1 Acute Heart Failure (AHF) Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Acute Heart Failure (AHF) Therapeutics Product Type
- 3.4.3 Date of International Manufacturers Enter into Acute Heart Failure (AHF) Therapeutics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Acute Heart Failure (AHF) Therapeutics Sales by Product
- 4.2 Global Acute Heart Failure (AHF) Therapeutics Revenue by Product
- 4.3 Acute Heart Failure (AHF) Therapeutics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Acute Heart Failure (AHF) Therapeutics Breakdown Data by End User
6 North America
- 6.1 North America Acute Heart Failure (AHF) Therapeutics by Countries
- 6.1.1 North America Acute Heart Failure (AHF) Therapeutics Sales by Countries
- 6.1.2 North America Acute Heart Failure (AHF) Therapeutics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Acute Heart Failure (AHF) Therapeutics by Product
- 6.3 North America Acute Heart Failure (AHF) Therapeutics by End User
7 Europe
- 7.1 Europe Acute Heart Failure (AHF) Therapeutics by Countries
- 7.1.1 Europe Acute Heart Failure (AHF) Therapeutics Sales by Countries
- 7.1.2 Europe Acute Heart Failure (AHF) Therapeutics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Acute Heart Failure (AHF) Therapeutics by Product
- 7.3 Europe Acute Heart Failure (AHF) Therapeutics by End User
8 Asia Pacific
- 8.1 Asia Pacific Acute Heart Failure (AHF) Therapeutics by Countries
- 8.1.1 Asia Pacific Acute Heart Failure (AHF) Therapeutics Sales by Countries
- 8.1.2 Asia Pacific Acute Heart Failure (AHF) Therapeutics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Acute Heart Failure (AHF) Therapeutics by Product
- 8.3 Asia Pacific Acute Heart Failure (AHF) Therapeutics by End User
9 Central & South America
- 9.1 Central & South America Acute Heart Failure (AHF) Therapeutics by Countries
- 9.1.1 Central & South America Acute Heart Failure (AHF) Therapeutics Sales by Countries
- 9.1.2 Central & South America Acute Heart Failure (AHF) Therapeutics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Acute Heart Failure (AHF) Therapeutics by Product
- 9.3 Central & South America Acute Heart Failure (AHF) Therapeutics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Acute Heart Failure (AHF) Therapeutics by Countries
- 10.1.1 Middle East and Africa Acute Heart Failure (AHF) Therapeutics Sales by Countries
- 10.1.2 Middle East and Africa Acute Heart Failure (AHF) Therapeutics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Acute Heart Failure (AHF) Therapeutics by Product
- 10.3 Middle East and Africa Acute Heart Failure (AHF) Therapeutics by End User
11 Company Profiles
- 11.1 Bayer AG
- 11.1.1 Bayer AG Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bayer AG Acute Heart Failure (AHF) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bayer AG Acute Heart Failure (AHF) Therapeutics Products Offered
- 11.1.5 Bayer AG Recent Development
- 11.2 Bristol-Myers Squibb Company
- 11.2.1 Bristol-Myers Squibb Company Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Products Offered
- 11.2.5 Bristol-Myers Squibb Company Recent Development
- 11.3 Cardiorentis AG
- 11.3.1 Cardiorentis AG Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Products Offered
- 11.3.5 Cardiorentis AG Recent Development
- 11.4 CVie Therapeutics Limited
- 11.4.1 CVie Therapeutics Limited Company Details
- 11.4.2 Company Business Overview
- 11.4.3 CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Products Offered
- 11.4.5 CVie Therapeutics Limited Recent Development
- 11.5 Cytokinetics, Inc.
- 11.5.1 Cytokinetics, Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Products Offered
- 11.5.5 Cytokinetics, Inc. Recent Development
- 11.6 Merck & Co.
- 11.6.1 Merck & Co. Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Merck & Co. Acute Heart Failure (AHF) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Merck & Co. Acute Heart Failure (AHF) Therapeutics Products Offered
- 11.6.5 Merck & Co. Recent Development
- 11.7 Novartis AG
- 11.7.1 Novartis AG Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Novartis AG Acute Heart Failure (AHF) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Novartis AG Acute Heart Failure (AHF) Therapeutics Products Offered
- 11.7.5 Novartis AG Recent Development
- 11.8 Orion Corporation
- 11.8.1 Orion Corporation Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Orion Corporation Acute Heart Failure (AHF) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Orion Corporation Acute Heart Failure (AHF) Therapeutics Products Offered
- 11.8.5 Orion Corporation Recent Development
- 11.9 PhaseBio Pharmaceuticals, Inc
- 11.9.1 PhaseBio Pharmaceuticals, Inc Company Details
- 11.9.2 Company Business Overview
- 11.9.3 PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Products Offered
- 11.9.5 PhaseBio Pharmaceuticals, Inc Recent Development
12 Future Forecast
- 12.1 Acute Heart Failure (AHF) Therapeutics Market Forecast by Regions
- 12.1.1 Global Acute Heart Failure (AHF) Therapeutics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Acute Heart Failure (AHF) Therapeutics Revenue Forecast by Regions 2019-2025
- 12.2 Acute Heart Failure (AHF) Therapeutics Market Forecast by Product
- 12.2.1 Global Acute Heart Failure (AHF) Therapeutics Sales Forecast by Product 2019-2025
- 12.2.2 Global Acute Heart Failure (AHF) Therapeutics Revenue Forecast by Product 2019-2025
- 12.3 Acute Heart Failure (AHF) Therapeutics Market Forecast by End User
- 12.4 North America Acute Heart Failure (AHF) Therapeutics Forecast
- 12.5 Europe Acute Heart Failure (AHF) Therapeutics Forecast
- 12.6 Asia Pacific Acute Heart Failure (AHF) Therapeutics Forecast
- 12.7 Central & South America Acute Heart Failure (AHF) Therapeutics Forecast
- 12.8 Middle East and Africa Acute Heart Failure (AHF) Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Acute Heart Failure (AHF) Therapeutics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Acute Heart Failure (AHF) Therapeutics . Industry analysis & Market Report on Acute Heart Failure (AHF) Therapeutics is a syndicated market report, published as Global Acute Heart Failure (AHF) Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Acute Heart Failure (AHF) Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
